TMED2 and plasma cell myeloma: Ge et al. discovered that MM.1S and RPMI8226, two multiple myeloma cell lines, had high levels of TMED2 expression, and that silencing TMED2 resulted in a significant drop in viability and an increase in apoptosis, indicating TMED2 may be crucial in the pathogenesis of multiple myeloma 82.